Paul J. Galardy

3.9k total citations
55 papers, 2.8k citations indexed

About

Paul J. Galardy is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Paul J. Galardy has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Paul J. Galardy's work include Ubiquitin and proteasome pathways (28 papers), Protein Degradation and Inhibitors (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Paul J. Galardy is often cited by papers focused on Ubiquitin and proteasome pathways (28 papers), Protein Degradation and Inhibitors (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Paul J. Galardy collaborates with scholars based in United States, Netherlands and Italy. Paul J. Galardy's co-authors include Hidde L. Ploegh, Sajjad Hussain, Huib Ovaa, Benedikt M. Kessler, Ying Zhang, Edda Fiebiger, Jan van Deursen, Alan D. D’Andrea, Tony T. Huang and Wilhelm Haas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Paul J. Galardy

52 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul J. Galardy United States 25 2.3k 971 391 298 256 55 2.8k
Susan Wee United States 16 2.1k 0.9× 702 0.7× 255 0.7× 295 1.0× 198 0.8× 27 2.6k
Daniel P. Sutherlin United States 23 2.3k 1.0× 832 0.9× 286 0.7× 343 1.2× 392 1.5× 32 3.1k
Emily A. Liu United States 5 2.9k 1.3× 2.3k 2.3× 352 0.9× 489 1.6× 239 0.9× 5 3.9k
Matthew R. Janes United States 15 2.2k 1.0× 594 0.6× 160 0.4× 273 0.9× 285 1.1× 26 2.7k
Hetal Patel United Kingdom 19 2.3k 1.0× 2.1k 2.2× 377 1.0× 469 1.6× 476 1.9× 35 3.5k
Kathryn Packman United States 28 2.6k 1.1× 2.2k 2.3× 278 0.7× 484 1.6× 286 1.1× 65 3.9k
Cassandra J. Vandenberg Australia 19 2.2k 0.9× 912 0.9× 165 0.4× 345 1.2× 553 2.2× 44 2.9k
Lyubomir T. Vassilev United States 22 2.1k 0.9× 1.4k 1.5× 596 1.5× 328 1.1× 115 0.4× 37 2.8k
Pietro Taverna United States 27 1.8k 0.8× 788 0.8× 155 0.4× 359 1.2× 286 1.1× 90 2.5k
Jingsong Yang United States 21 1.4k 0.6× 898 0.9× 309 0.8× 137 0.5× 250 1.0× 37 2.1k

Countries citing papers authored by Paul J. Galardy

Since Specialization
Citations

This map shows the geographic impact of Paul J. Galardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Galardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Galardy more than expected).

Fields of papers citing papers by Paul J. Galardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Galardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Galardy. The network helps show where Paul J. Galardy may publish in the future.

Co-authorship network of co-authors of Paul J. Galardy

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Galardy. A scholar is included among the top collaborators of Paul J. Galardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Galardy. Paul J. Galardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thompson, Whitney S., et al.. (2024). Neonatal hemophagocytic lymphohistiocytosis: A meta‐analysis of 205 cases. Pediatric Blood & Cancer. 71(4). e30894–e30894. 5 indexed citations
3.
Block, Darci R, et al.. (2024). The Global Prevalence of Iron Deficiency in Collegiate Athletes: A Systematic Review and Meta‐Analysis. Pediatric Blood & Cancer. 72(2). e31415–e31415. 1 indexed citations
4.
Galardy, Paul J., et al.. (2023). Attempted desensitization to calaspargase pegol: a familiar approach to a new problem. Leukemia & lymphoma. 65(3). 407–409. 2 indexed citations
5.
Galardy, Paul J., et al.. (2023). An Effective Combination Therapy for the Treatment of Pediatric Monomorphic Post-transplant Lymphoproliferative Disorder With Plasmacytic Differentiation. Journal of Pediatric Hematology/Oncology. 45(5). e624–e627. 1 indexed citations
6.
Traynor, Michael D., D. Dean Potter, Michael B. Ishitani, et al.. (2021). Evolution of pediatric gastrointestinal ulcer disease: Is acute surgical intervention relevant?. Journal of Pediatric Surgery. 56(10). 1870–1875. 2 indexed citations
7.
Bedekovics, Tibor, et al.. (2020). USP24 Is a Cancer-Associated Ubiquitin Hydrolase, Novel Tumor Suppressor, and Chromosome Instability Gene Deleted in Neuroblastoma. Cancer Research. 81(5). 1321–1331. 16 indexed citations
8.
Frazer, J. Kimble, Kevin J. Li, Paul J. Galardy, et al.. (2018). Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. British Journal of Haematology. 185(2). 374–377. 14 indexed citations
9.
Hussain, Sajjad, Tibor Bedekovics, Qiuying Liu, et al.. (2018). UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice. Blood. 132(24). 2564–2574. 31 indexed citations
10.
Galardy, Paul J., Jessica Hochberg, Sherrie L. Perkins, et al.. (2013). Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B‐NHL: a Children's Oncology Group Report. British Journal of Haematology. 163(3). 365–372. 39 indexed citations
11.
Zhang, Ying, Oded Foreman, Dennis A. Wigle, et al.. (2012). USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. Journal of Clinical Investigation. 122(12). 4362–4374. 138 indexed citations
12.
Zhang, Ying, Jan van Deursen, & Paul J. Galardy. (2011). Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia. PLoS ONE. 6(8). e23389–e23389. 55 indexed citations
13.
Kumar, Riten, Paul J. Galardy, Ahmet Doǧan, Vilmarie Rodriguez, & Shakila P. Khan. (2011). Rituximab in combination with multiagent chemotherapy for Pediatric follicular lymphoma. Pediatric Blood & Cancer. 57(2). 317–320. 15 indexed citations
14.
15.
Catic, André, Edda Fiebiger, Gregory A. Korbel, et al.. (2007). Screen for ISG15-crossreactive Deubiquitinases. PLoS ONE. 2(7). e679–e679. 85 indexed citations
16.
Baker, Darren J., Meelad M. Dawlaty, Paul J. Galardy, & Jan M. van Deursen. (2007). Mitotic regulation of the anaphase-promoting complex. Cellular and Molecular Life Sciences. 64(5). 589–600. 76 indexed citations
17.
Huang, Tony T., Sebastian Nijman, Paul J. Galardy, et al.. (2006). Regulation of monoubiquitinated PCNA by DUB autocleavage. Nature Cell Biology. 8(4). 341–347. 466 indexed citations
18.
Ovaa, Huib, Paul J. Galardy, & Hidde L. Ploegh. (2005). Mechanism‐Based Proteomics Tools Based on Ubiquitin and Ubiquitin‐Like Proteins: Synthesis of Active Site‐Directed Probes. Methods in enzymology on CD-ROM/Methods in enzymology. 399. 468–478. 14 indexed citations
19.
Ovaa, Huib, Paul F. van Swieten, Benedikt M. Kessler, et al.. (2003). Chemistry in Living Cells: Detection of Active Proteasomes by a Two‐Step Labeling Strategy. Angewandte Chemie International Edition. 42(31). 3626–3629. 147 indexed citations
20.
Cox, Josephine H., Paul J. Galardy, Jack R. Bennink, & J W Yewdell. (1995). Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines.. The Journal of Immunology. 154(2). 511–519. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Wee Breakdown of academic impact, for papers by Daniel P. Sutherlin Breakdown of academic impact, for papers by Emily A. Liu Breakdown of academic impact, for papers by Matthew R. Janes Breakdown of academic impact, for papers by Hetal Patel Breakdown of academic impact, for papers by Kathryn Packman Breakdown of academic impact, for papers by Cassandra J. Vandenberg Breakdown of academic impact, for papers by Lyubomir T. Vassilev Breakdown of academic impact, for papers by Pietro Taverna Breakdown of academic impact, for papers by Jingsong Yang
Rankless by CCL
2026